SavedAdd your journal

Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 1

Familial Branch Retinal Vein Occlusion

Ailesel Retinal Ven Dal Tıkanıklığı

SİREL GÜR GÜNGÖR
Almila SARIGÜL
İmren AKKOYUN
Ahmet AKMAN
Gürsel YILMAZ
Sema KARAKUŞ
Pages
75–79
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient was heterozygous for the C677T mutation of the MTHFR gene and her homocystein level was within normal limits

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 56-year-old male patient, with a complaint of blurred vision in his left eye, was referred to our clinic 5 years ago.
📊
Key Findings & Data:His visual acuity was 20/60 in the left eye.
💡
Conclusion & Impact:The patient was heterozygous for the C677T mutation of the MTHFR gene and her homocystein level was within normal limits
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 56-year-old male patient, with a complaint of blurred vision in his left eye, was referred to our clinic 5 years ago. His visual acuity was 20/60 in the left eye. Dilated fundus examination revealed superior temporal branch retinal vein occlusion and macular edema in the left eye. The patients was homozygous for the C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) and arterial hypertension, high blood homocysteine level, low blood vitamin B12 and folic acid levels were detected after systemic evaluation. Approximately 2 years later, his 40-year-old daughter had a complaint of blurred vision in her right eye. Her visual acuity was 20/40 in the right eye. In the fundus examination of the right eye, superior temporal branch retinal vein occlusion and macular edema were noticed. The patient was heterozygous for the C677T mutation of the MTHFR gene and her homocystein level was within normal limits

Özet

Elli altı yaşında erkek hasta 5 yıl önce sol gözde görme bulanıklığı ile kliniğimize başvurdu. Görme keskinliği sol gözde 20/60 düzeyindeydi. Dilate fundus muayenesinde sol gözde üst temporal retinal ven dal tıkanıklığı ve maküler ödem tespit edildi. Yapılan sistemik inceleme sonrası arteriyel hipertansiyon, metiltetradihrofolat redüktaz (MTHFR) C677T mutasyonu homozigotluğu, yüksek homosistein düzeyi, düşük vitamin B12 düzeyi ve düşük folik asit düzeyi olduğu saptandı. Yaklaşık 2 yıl sonra 40 yaşındaki kızı sağ gözde görme bulanıklığı ile başvurdu. Sağ gözde görme keskinliği 20/40 idi. Sağ fundus muayenesinde üst temporal ven dal tıkanıklığı ve maküler ödem mevcuttu. Hastanın MTHFR C677T mutasyonu yönünden heterozigot olduğu ve homosistein düzeyinin normal sınırlarda olduğu saptandı

🔖

Cite This Article

GÜNGÖR, S. G., SARIGÜL, A., AKKOYUN, İ., AKMAN, A., YILMAZ, G., KARAKUŞ, S. (2015). Familial Branch Retinal Vein Occlusion. Retina-Vitreus, Cilt: 23 - Sayı: 1, 75–79. https://ajindex.com/articles/307649

References (16)

  1. Rehak J, Rehak M. Branch retinal vein occlusion: pathogene- sis, visual prognosis, and treatment modalities. Curr Eye Res 2008;33:111-31.
  2. Frangieh GT, Green RW, Barraquer-Somers E, et al. Histo- pathologic study of nine branch retinal vein occlusions. Arch Ophthalmol 1982; 100:1132-40.
  3. Zhao J, Sastry SM, Sperduto RD et al. Arteriovenous cross- ing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology 1993;100:423-8.
  4. Fekrat S, Finkelstein D. Venous occlusive disease. In Regillo CD, Brown GC, Flynn HW Jr: Vitreoretinal disease. The Es- sentials. New York, Stuttgart: Thieme; 1999;P:117-32. Janssen MC, den Heijer M, Cruysberg JR et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A metaanalysis of thrombophilic factors. Thromb Haemost 2005;93:1021-6.
  5. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and ther- molabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136:1136-50.
  6. Müftüoğlu G, Akar S, Ocakoğlu Ö, Özkan Ş. Glokomlu olgu- larda meydana gelen ven tıkanıklıklarının incelenmesi. Ret- Vit 1997;5:13-5.
  7. Balcı Ö, Engör E: Retina ven tıkanıklıkları. T Oft Gaz 2004;34:445-55.
  8. Yau JWY, Lee P, Wong TY et al. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med 2008;38:904-10.
  9. Hayreh SS, Zimmerman B, McCarthy MJ et al. Systemic dis- eases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77.
  10. Di Capua M, Coppola A, Albisinni R et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis 2009;30:16-22.
  11. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126:692-9.
  12. Arsene S, Delahousse B, Regina S et al. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost 2005;94:101-106.
  13. Larsson J, Hultberg B, Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlu- sion. Acta Ophthalmol Scand 2000;78:340-3.
  14. Young IS, Woodside JV. Folate and homocysteine. Curr Opin Clin Nutr Metab Care 2000;3:427-32.
  15. Boushey CJ, Beresford SA, Omenn GS et al. A quantitative assessment of plasma homocysteine as a risk factor for vascu- lar disease. JAMA 1995;274:1049-57.
  16. Cahill M, Karabatzaki M, Meleady R et